CTRI/2023/10/058546尚未招募2 期
Comparison of outcome in Terlipressin and ultra-low dose Terlipressin plus noradrenalin infusion in HRS-AKI patients of ACLF - NI
on sponsered0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •ACLF as per APASL criteria
- •AKI at admission as defined by ICA-AKI criteria
- •HRS-AKI grade II & grade III as defined by ICA 12 hour of admission
排除标准
- •Age <18 years >70 years
- •Septic shock
- •Patient with HCC outside Milan’s criteria
- •Severe Hyponatremia (Na <120 MEq/L)
- •Patients with RH failure, CAD, PVD, arrhythmias and cardiomyopathy
- •Pregnancy or Lactating mother
- •Grade III/IV HE or Shock requiring inotropes or patients on mechanical ventilator at time of randomization
- •In-hospital new AKI
- •Active urinary sediments – 2+ albumin or above, dysmorphic RBCs
- •Known CKD, obstructive uropathy
- •Lack of informed consent
- •Prior intolerance or S/E to Terlipressin or albumin
研究者
相似试验
尚未招募
不适用
A clinical trial to study the efficiency of two drugs terlipressin and noradrenaline in patients with low blood pressure and liver failure.CTRI/2021/09/036920Pt BD Sharma Pgims rohtak
已完成
不适用
Treatment for renal failure in chronic liver diseaseCTRI/2011/09/002032SKIMS university60
已完成
不适用
To compare low cost treatment regimen with standard treatment in patients with hepatorenal syndromeCTRI/2011/07/001860il80
尚未招募
不适用
Role of Terlipressin in maintaning blood pressure in a patient going into shock because of sepsisCTRI/2019/10/021484Hospital Supplies AIIMS Jodhpur
尚未招募
3 期
Outpatient terlipressin infusion for the prevention of liver events in cirrhosiscirrhosisACTRN12624000903583Austin Health100